DNMT3A and cancer: Moreover, numerous studies have documented sex‐specific DNA methylation patterns across contexts such as brain development, neurodegeneration, chemical exposure, and cancer.[25] Observing sex‐biased DNMT3a expression in the mPFC following PTX treatment underscores the importance of considering sex differences in epigenetic modifications and their implications for therapeutic strategies.